Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference
Penumbra, Inc. (NYSE: PEN) has announced its participation in the upcoming Wells Fargo Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Penumbra, Inc. (NYSE: PEN) has announced its participation in the upcoming Wells Fargo Healthcare Conference. The company's management team is scheduled to present on Wednesday, September 4, 2024, at 2:15pm ET/11:15am PT. Interested parties can access a webcast of the presentation through the 'Events and Presentations' section under the 'Investors' tab on Penumbra's official website.
The webcast will remain available on the company's website for a minimum of two weeks following the event. This presentation provides an opportunity for investors and analysts to gain insights into Penumbra's current operations and future strategies within the healthcare sector.
Details
News Market Reaction – PEN
The recorded move for PEN in the trading session of this news was +1.21%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Event: | Wells Fargo Healthcare Conference |
Date: | Wednesday, September 4, 2024 |
Time: | 2:15pm ET/11:15am PT |
A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event.
About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.
Investor Relations
Penumbra, Inc.
investors@penumbrainc.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-wells-fargo-healthcare-conference-302226755.html
SOURCE Penumbra, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.